H44.113
Panuveitis, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Panuveitis, bilateral refers to the widespread inflammation of all uveal tract components—the iris, ciliary body, and choroid—in both eyes. This condition is classified under ICD-10 code H44.113 and requires prompt medical attention to prevent potential vision loss. It is a complex form of uveitis that involves multiple areas within the eye, leading to various visual disturbances and discomfort. Understanding the causes, symptoms, diagnosis, and treatment options can help patients better comprehend the condition and its implications.
Causes & Symptoms
Clinical Causes: Autoimmune disorders such as sarcoidosis or Behçet's disease Infections including syphilis, tuberculosis, herpes viruses, and toxoplasmosis Idiopathic cases where no identifiable cause is found Trauma or injury to the eyes Certain systemic inflammatory conditions
Key Symptoms: Redness and swelling in both eyes Blurred vision or decreased visual acuity Eye pain or discomfort Sensitivity to light (photophobia) Floaters or spots in the visual field Possible visual field loss or shadows
Diagnostic & Treatment
Diagnosis Path: Diagnosing bilateral panuveitis involves a thorough eye examination by an ophthalmologist, including slit-lamp examinations to assess inflammation and funduscopy to inspect the retina and choroid. Additional tests may include blood tests to identify underlying infections or autoimmune markers, imaging studies like optical coherence tomography (OCT), and sometimes, ocular fluid analysis. An accurate diagnosis often depends on a combination of clinical findings and laboratory investigations to determine the cause of inflammation.
Treatment Protocols: Treatment strategies focus on reducing inflammation, preventing complications, and addressing underlying causes. Common approaches include: - **Corticosteroids**: Administered orally, intravenously, or via eye drops to diminish inflammatory responses. - **Immunosuppressive Drugs**: Used in cases linked to autoimmune disorders, to control immune activity. - **Antimicrobial Therapy**: For infections like syphilis, tuberculosis, or herpes viral infections, targeted antibiotics or antiviral medications are prescribed. - **Supportive Care**: Including eye drops to reduce inflammation and manage discomfort, and regular monitoring of eye health. - **Surgical Interventions**: In severe cases or if complications such as glaucoma or cataracts develop, surgery may be necessary. Management plans are tailored to individual patients based on the severity of inflammation and the underlying cause, aiming to preserve vision and quality of life.
Clinical Advice & FAQs
Billing Guidance
Is H44.113 a billable ICD-10 code?
Yes, H44.113 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H44.113?
Clinical documentation must specify the nature of Panuveitis, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
